The widespread application of spatial transcriptomics in uncovering disease mechanisms remains limited by the scarcity of samples and the high experimental costs, which have not declined substantially in recent years. Unlocking the vast resources of clinical H&E-stained images could provide an efficient and cost-effective alternative for large-scale spatial analysis. However, predicting spatial gene expression from histopathological images remains challenging, as existing end-to-end frameworks often fail to capture the intrinsic transcriptomic structures observed in real transcriptomics data. To address this, we developed SciSt, a deep learning framework that predicts spatial gene expression by integrating pathological features with biologically informed initial gene expressions. These initial expressions are generated through a weighted strategy combining cell segmentation and single-cell reference data, thereby enhancing biological interpretability. SciSt achieved state-of-the-art performance across three benchmark datasets, outperforming the second-best models by 21.4% and 13.7%, respectively, and demonstrated robust generalization on the TCGA-BRCA and TCGA-LIHC cohorts. Beyond accurate prediction, SciSt enables cross-modal translation between morphology and gene expression, offering new avenues for mining the untapped potential of clinical image archives. This work highlights how prior biological knowledge can substantially advance the interpretability and scalability of biomedical AI models.

BACKGROUND: The complexity of biological systems has increasingly been unraveled through computational methods, with biological network analysis now focusing on the construction and exploration of well-defined interaction networks. Traditional graph-theoretical approaches have been instrumental in mapping key biological processes using high-confidence interaction data. However, these methods often struggle with incomplete or/and heterogeneous datasets. In this study, we extend beyond conventional bipartite models by integrating attribute-driven knowledge from the Molecular Signatures Database (MSigDB) using the node2vec algorithm. RESULTS: Our approach explores unsupervised biological relationships and uncovers potential associations between genes and biological terms through network connectivity analysis. By embedding both human and mouse data into a shared vector space, we validate our findings cross-species, further strengthening the robustness of our method. CONCLUSIONS: This integrative framework reveals both expected and novel biological insights, offering a comprehensive perspective that complements traditional biological network analysis and paves the way for deeper understanding of complex biological processes and diseases.

Cell-type annotation is a critical step in single-cell data analysis. With the development of numerous cell annotation methods, it is necessary to evaluate these methods to help researchers use them effectively. Reference datasets are essential for evaluation, but currently, the cell labels of reference datasets mainly come from computational methods, which may have computational biases and may not reflect the actual cell-type outcomes. This study first constructed an experimentally labeled immune cell-subtype single-cell dataset of the same batch and systematically evaluated 18 cell annotation methods. We assessed those methods under five scenarios, including intra-dataset validation, immune cell-subtype validation, unsupervised clustering, inter-dataset annotation, and unknown cell-type prediction. Accuracy and ARI were evaluation metrics. The results showed that SVM, scBERT, and scDeepSort were the best-performing supervised methods. Seurat was the best-performing unsupervised clustering method, but it couldn't fully fit the actual cell-type distribution. Our results indicated that experimentally labeled immune cell-subtype datasets revealed the deficiencies of unsupervised clustering methods and provided new dataset support for supervised methods.

MOTIVATION: Screening new drug-target interactions (DTIs) by traditional experimental methods is costly and time-consuming. Recent advances in knowledge graphs, chemical linear notations, and genomic data enable researchers to develop computational-based-DTI models, which play a pivotal role in drug repurposing and discovery. However, there still needs to develop a multimodal fusion DTI model that integrates available heterogeneous data into a unified framework. RESULTS: We developed MDTips, a multimodal-data-based DTI prediction system, by fusing the knowledge graphs, gene expression profiles, and structural information of drugs/targets. MDTips yielded accurate and robust performance on DTI predictions. We found that multimodal fusion learning can fully consider the importance of each modality and incorporate information from multiple aspects, thus improving model performance. Extensive experimental results demonstrate that deep learning-based encoders (i.e. Attentive FP and Transformer) outperform traditional chemical descriptors/fingerprints, and MDTips outperforms other state-of-the-art prediction models. MDTips is designed to predict the input drugs' candidate targets, side effects, and indications with all available modalities. Via MDTips, we reverse-screened candidate targets of 6766 drugs, which can be used for drug repurposing and discovery. AVAILABILITY AND IMPLEMENTATION: https://github.com/XiaoqiongXia/MDTips and https://doi.org/10.5281/zenodo.7560544.

MOTIVATION: Knowledge Graph (KG) is becoming increasingly important in the biomedical field. Deriving new and reliable knowledge from existing knowledge by KG embedding technology is a cutting-edge method. Some add a variety of additional information to aid reasoning, namely multimodal reasoning. However, few works based on the existing biomedical KGs are focused on specific diseases. RESULTS: This work develops a construction and multimodal reasoning process of Specific Disease Knowledge Graphs (SDKGs). We construct SDKG-11, a SDKG set including five cancers, six non-cancer diseases, a combined Cancer5 and a combined Diseases11, aiming to discover new reliable knowledge and provide universal pre-trained knowledge for that specific disease field. SDKG-11 is obtained through original triplet extraction, standard entity set construction, entity linking and relation linking. We implement multimodal reasoning by reverse-hyperplane projection for SDKGs based on structure, category and description embeddings. Multimodal reasoning improves pre-existing models on all SDKGs using entity prediction task as the evaluation protocol. We verify the model's reliability in discovering new knowledge by manually proofreading predicted drug-gene, gene-disease and disease-drug pairs. Using embedding results as initialization parameters for the biomolecular interaction classification, we demonstrate the universality of embedding models. AVAILABILITY AND IMPLEMENTATION: The constructed SDKG-11 and the implementation by TensorFlow are available from https://github.com/ZhuChaoY/SDKG-11. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.